Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Scancell Holdings Share News (SCLP)

Scancell founder says the company is ready to commercialise novel medicines to counteract cancer

Scancell founder says the company is ready to commercialise novel medicines to counteract cancer

Scancell Holdings Information

Buy SCLP Shares
Add SCLP to Watchlist
Add SCLP to Alert

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange

Share Price is delayed by 15 minutes

Share Price: 10.25

Bid: 9.50

Ask: 11.00

Change: 0.00 (0.00%)

Spread: 1.50 (15.789%)

Open: 10.25

High: 10.40

Low: 10.00

Prev. Close: 10.25

SCLP Live Price

Last checked at -

UK AGM, EGM Calendar - Week Ahead

Mon, 13th Oct 2014 05:30

UK AGM, EGM Calendar

Monday, October 13

No Events Scheduled

Tuesday, October 14

Brack Capital Real Estate Investments

Frontier Developments

Scancell Holdings

Xplorer

Investors in Global Real Estate

Assura Group

Wednesday, October 15

No Events Scheduled

Thursday, October 16

Cambium GlobalTimber

IG Group Holdings

Rank Group

Renishaw

Aberforth Geared Income Trust

Consort Medical

Pantheon International Participations

Friday, October 17

John Swan & Sons

Bluefield Solar Income Fund

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News

18 May 2016 08:06

Scancell Shuffles Board As New US Offices Open, Plans For Oxford Base

4 Apr 2016 11:47

Scancell raises £6.2m in placing and open offer

(ShareCast News) - Scancell revealed the final results of its placing and open offer on Monday, with a few more subscriptions received since the firm's last update on 1 April. The AIM-traded company had announced on Friday that it had received subscriptions for 16,048,593 new ordinary shares of the

4 Apr 2016 09:31

Scancell Raises Further Funding Through Open Offer (ALLISS)

1 Apr 2016 11:27

CORRECT: Scancell Raises Funds In Placing, Open Offer (ALLISS)

1 Apr 2016 09:06

Scancell Raises Total Of GBP6.1 Million In Placing, Open Offer (ALLISS)

11 Mar 2016 08:51

Scancell skips higher on Swedish research collaboration

(ShareCast News) - Immuno-oncology specialist Scancell has impressed investors with a new research partnership with Sweden's Karolinska Institutet into the role of citrullinated proteins in the treatment of cancer. Both parties have uncovered important roles that citrullinated proteins can play in h

11 Mar 2016 08:01

Scancell Signs Strategic Research Agreement With Karolinska Institutet

9 Mar 2016 16:25

CORRECT: UPDATE: Scancell Holdings Raises GBP3.4 Million (ALLISS)

9 Mar 2016 14:28

UPDATE: Scancell Holdings Raises GBP7.2 Million To Back Pipeline (ALLISS)

9 Mar 2016 09:57

Scancell Holdings Plans To Raise GBP6.8 Million To Back Pipeline (ALLISS)

27 Jan 2016 10:43

Scancell Pretax Loss Narrows As Development Of Treatments Continues

11 Jan 2016 08:18

Scancell Holdings Gets Good Results From SCIB1 Cancer Trials

7 Jan 2016 08:32

Scancell Appoints New Chairman To Lead US Market Push

5 Jan 2016 08:16

Scancell Welcomes Supportive Paper In Cancer Research Journal

18 Dec 2015 10:49

Scancell To Undertake Phase II Study Of Cancer Vaccine SCIB1